Abstract
Introduction
Fibrous dyspla sia is a rare, nonneoplastic bone disea se in which osteoblasts are incapable of producing matur e trabecular bone. It usually arises in patients between the ages of 5 and 15 years. Fibrous dysplasia is belie ved to be caused by a mutati on of the ge ne that code s for the subunit of the Gs protein , a signal protein located on the cell membrane. The mutation leads to a loss of guanosine triphosphatase activity and thus to adenyl cyclase overactivity and subsequent overproduction of cyclic aden osine monophosphate (cAMP). It is the co ntinuous cAMP stimulation that appears to be responsible for the onset of From In this article, we describe a case of monostotic fibrous dysplasia in a middle-aged woman who responded well to medical treatment.
Case report
A 54-year-old woman presented to our outpatient clinic with a IS-year history of frontal headache and a perm anent feeling of pressure over the right frontal sinus. She had been referred to us after bony changes in the area of the right frontal sinus were found incident ally on dental x-rays . She had no history of ocular symptoms. She was tak ing a nonsteroid al anti-inflammatory drug for relief of chronic back pain.
Examination revea led a slight protub erance over the area of the right frontal sinus. No tend erness was evident on palpation of the supraorbital foramen. Th e ENT examination detected no pathology.
Comput ed tomography (CT) of the paran asal sinuses revealed widenin g of the frontal bone with exten sive medial and right later al osteolyti c structural changes in the canc ellou s bone of the diplo e (figure I). No perforation of the internal or external lamin a was noted, althou gh the external lamina was markedly erod ed.
Partial multiphase skeletal scintigraphy and single-photon emission CT of the cranium showed incre ased bone metabolism in the area of the right front al bone, starting in the ethmoid cells in the roof of the orbit and extending slightly to the left (figure 2). Skeletal scintigraphy provided no further indication of the charac teristics of the lesion. Right-sided frontal hyperostosis could not be ruled out in the differenti al diagnosis.
As expected, the areas of increased lysis in the frontal bone seen on coronal CT exhibited evidence of normal to decreased bone metabolism. Second ary findings included a dental focu s in the right maxilla and pron ounced degenerative changes in the enti re vertebral column; the degeneration was most pronounced in the costovertebral jo ints and in the facet join ts of the lumb ar spine. Arthritic changes were seen in both knee joints. No other hot spots of increased bone activity were see n.
To rule out Paget's disease, assays of inorganic phosph ate and calcium were obtained ; both values were within normal There is general agreement that a hypertonic saline solution improves the upper respiratory tract's natural filtration system, when used regularly.* That's the catch, used regularly.
Introducing Saltaire" Sinus Relief, the sinus wash system that is so convenient and easy for your patients to use, that they will follow your recommended treatment and use it.
No mixing, no measuring. No drugs. Your patient simply squeezes the bellows on the patented dispenser bottle, and a gentle flow of a precisely balanced, buffered saline solution wash is delivered directly to the nasal cavity and sinuses. Rinsing with SaltAire washes away mucus and trapped inhalants. Patients report dramatic relief from sinusitis, congestion and allergy symptoms, and improved ability to breathe.
Recommend SaltAire. It is an effective way for your patients to realize the benefits of a hypertonic saline wash. Easy to find on the shelves of major and independent pharmacies. And so easy to use, think of it as a day at the beach. Visit www.saltairesinusrelief.com or call 1-888-SINUSRX for more information. limit s (2.6 mg/dl and 2.38 mmol/L, respecti vely ). A urine hydro xyproline assay also yielded a norm al result of 2.7 nmol (range of norm al: 2.5 to 9.5).
The final diagno sis of fibrous dysplasia was established by tissue biopsy. The patient was prescribed bisphosphonates for symptom relief. At follo w-up 1 year later, the patient remained asymptomatic, and CTfound no evidence oflesion progression. The patient was scheduled to undergo yearly follow-up CTs indefinitely.
Discussion
Fibrous dysplasia of the bone (Jaffe-Lichtenstein syndrome, osteodystroph ia fibrosa) was first described by Lichtenstein in 1938.
1 It accounts for approximately 2.5% of all bone tumors, and famili al cases have been reported.' Fibrous dysplasia typically occurs in patient s between the ages of 5 and 15 years, and it spontaneously resolve s durin g pubert y in 60 to 80% of patients.' Most of these tumors arise unilaterally in the skull and femoral bone s. The incidenc e of craniofacial manifestations of fibrou s dysplasia ranges bet ween 10 and 32%. 3 The disorder is classified clinically as either monostotic or polyostotic.
The mon ostotic for m occurs in 70 to 80% of patien ts. J.2 It generally occurs durin g the seco nd decade of life and becomes dorm ant by the third decade. Hormonal changes, such as those seen in pregnancy, can reactivate a dormant lesion. ' The polyostotic form most often affects the skull and facial cra nium; the pelvis, spine, and shoulder girdle have also been invo lved, but involvement of the extremities is rare. Patient s with the polyostotic form generally present with numerou s head and neck symptoms, such as a loss of hearing, recurrent sinusitis, nasal obstruction, protru sio bulbi , or co mpressio n of the optic nerve, which can lead to blindness.' In a fe w cases, the polyostotic form has been associated with end ocrinopathies. A specia l type of polyostotic fibrous dyspl asia is McCune-Albright syndrome, which is associated with precocious sexual development and cafe au lait spots on the skin.' The cause is belie ved to involve a point mut ation on chrom osome 20 (20q I2-qI 3) within the Gs alpha regi on; as a result of the mutation , the activity of the Gs protein , and thus of adenyl cyclase, is increased.
The diagnosis in our patient was established on the basis of the history, phy sical examination, and radio logic, laboratory, and pathologic inves tigations. The diagno stic tests we performed were ordered to rule out involvement of important anatomic struc tures , such as the optic nerve. When we were unable to find any such complications, we prescribed symptomatic pain therapy, mainly bisphosphonates. Surgical exc ision of this slow ly growi ng benign tumor was not indicated in this case. Findings at the I-year follow-up confirmed that watch-and-wait is an acceptable policy in cases of fibrou s dysplasia.
Bisphosphonate s are potent inhibitors of bone absorption.t" In adults, general metab olic disorders such as 
